CV pathophysiology Flashcards
high risk procedures for a patient with CAD include (4)
emergency surgery (esp in elderly)
open aortic surgery
peripheral vascular surgery
long surgical procedures with volume shifts and/or blood loss
general risk factors for cardiac risk patients include (6)
high risk surgery
hx of ischemic heart disease (unstable angina confers greatest risk of perioperative MI)
CHF
CVD
DM
serum creatinine >2
risk of reinfarction after MI is:
>6 mo:
3-6 mo:
<3 mo:
> 6 mo: 6%
3-6 mo: 15%
<3 mo: 30%
intermediate risk surgeries include (5)
CEA
head and neck surgery
intrathoracic or inter peritoneal surgery
ortho surgery
prostate surgery
low risk surgeries include (5)
endoscopic procedures
cataract surgery
superficial procedures
breast surgery
ambulatory procedures
NYHA classification, level of impairment, and functional limitation (4 classes)
which classes of NYHA patients should be referred to a cardiologist before surgery
class 3 or 4
unless its a minor procedure under MAC
PAOP is a surrogate for
LVEDP
ex) CPP=DBP-LVEDP but only have PAOP
CKMB initial elevation, peak elevation, return to baseline after MI
initial: 3-12h (same as Troponin I and T)
peak elevation: 24h
return to baseline: 2-3d
Troponin I initial elevation, peak elevation, return to baseline after MI
initial: 3-12h (same as CKMB and troponin T)
peak elevation: 24h
return to baseline: 5-10d
Troponin T initial elevation, peak elevation, return to baseline after MI
initial: 3-12h (same as CKMB and Troponin I)
peak elevation: 12-48h
return to baseline: 5-14d
best leads to use to detect an MI and WHY
leads II, V5.
lead II: aids in ID of inferior wall ischemia. also monitors for dysrhythmias where QRS is narrow and P wave is crucial for dx
V5: classic teaching says this is best for LV ischemia but new data says maybe V3/4 is best,
CHOOSE V4 on NCBRNA***
CVP and PAOP may over estimate LVEDV for any condition that does what?
reduces ventricular compliance
name examples that would shift the compliance curve to the red (highest) (5)
age >60y
ischemia
pressure overload hypertrophy (aortic stenosis or HTN)
hypertrophic obstructive cardiomyopathy
pericardial pressure (increased external pressure)
etiology of HFrEF (systolic failure)
pumping problem
MI
valve insufficiency
dilated cardiomyopathy
etiology of HF with preserved EF (diastolic failure) (7)
filling problem
MI
valve stenosis
HTN
hypertrophic cardiomyopathy
cor pulmonale **
obesity*
compare systolic HF and diastolic HF in terms of
EDV
EDP
ESV
SV
LV mass
LV geometry
which drugs can reverse cardiac remodeling
ACEI’s and spironolactone (aldosterone antagonists)
compare anesthetic management of systolic HF and diastolic HF in terms of
preload
afterload
contractility
HR
most common cause of RV failure
LV failure
tx for RV failure includes
inotropes (milrinone, dobut)
pulmonary vasodilators (inhaled NO or sildenafil, PDE5)
reverse cause of increased PVR
conditions that increase PVR (5)
increased PEEP
N2O
Hothermia
acidosis
hypercarbia
list 4 physiologic adaptations of HF
- SNS activation
- excessive vasoconstriction
- fluid retention
- myocardial remodeling
3 physiologic functions of BNP
- natriuresis
- diuresis
- vasodilation
how does CHF effect beta receptors?
causes down regulation of beta receptors
most common cause of constrictive pericarditis
cardiac surgery
the patient has an aortic balloon pump. which part of this arterial BP waveform corresponds with diastolic augmentation and improvement of coronary BF?
remember balloons inflates during diastole. pressure is higher than unassisted systole. balloon deflates during systole to decrease after load.
which region of the pressure volume loop corresponds to S3 heart sound?
best heard during the middle 1/3 of diastole after S2 (aortic valve closure)
gallop, suggestive of HF but can be a normal finding in children and teens.
with a patient who has an LVAD, CO is highly dependent on
preload
mnemonic for debakey classification of aneurysm: BAD
B: both (type 1)
A: ascending (type 2)
D: descending (type 3)
stage 1 HTN
130-139 SBP OR 80-89 DBP
stage 2 HTN
SBP >140 OR DBP >90
stage 3 HTN (hypertensive crisis)
SBP >180 and/or DBP >120
cerebral auto regulation happens between a CPP of
50-150mmHg
what does chronic HTN do to cerebral auto regulation
SBP and DBP that permit anesthesia delay
SBP >180 and DBP >110
when does a HTN crisis turn into a HTN emergency
evidence of end organ damage ex) encephalopathy, stroke, papilledema, CHF, renal dysfunction
coarctation of aorta clinical findings and diagnostic tests
clinical findings: upper limb BP > lower limb BP, weak femoral pulse, systolic bruit, HTN
dx tests: aortography, echo, CT/MRI
renovascular disease clinical findings (3) and diagnostic tests (4)
clinical findings: HTN, bruit, severe HTN in young patient
dx tests: CT angiography, MRA, aortography, duplex ultrasonography
hyperadrenocorticism (cushings disease) clinical findings and diagnostic tests
clinical findings: HTN*, weight gain (truncal obesity), hyperglycemia, muscle and bone weakness, weakened immunity, hirsutism, moon face
dx: dexamethasone suppression test, glucose tolerance test, urinary cortisol, adrenal CT/MRI
hyperaldosteronism (conns disease) clinical findings and diagnostic tests
clinical findings: HTN*, hypokalemia, alkalosis, fatigue/weakness, parasthesia, nocturnal polyuria/polydipsia
dx: Cp aldosterone, Cp renin, Cp K, urinary potassium
pheochromocytoma clinical findings and diagnostic tests
clinical findings: HA, palpitations, diaphoresis
dx: plasma metanephrines, urinary catecholamines, urinary vanillylmandelic acid (VMA)
pregnancy induced HTN clinical findings (4) and diagnostic tests (4)
clinical findings: peripheral and pulmonary edema, HA, sz, RUQ pain
dx: urinary protein, platelet count, uric acid, CO
how alpha 1 antagonists decrease BP
decrease iCa2+ and decrease SVR
how B1 antagonists decrease BP
decrease inotropy, chronotropy, HR, dromotropy, and renin release from juxtaglomerular apparatus
selective B1 antagonists
acebutolol
atenolol
bisoprolol
esmolol
metoprolol
non selective b1 and b2 antagonists
nadolol
pindolol
propanolol
sotalol
timolol
mixed a1/b1/b2 antagonists
bucindolol, carvedilol, labetalol
how a2 agonists decrease BP
decrease SNS outflow
how CCB’s (dihydropiridines) decrease BP
decrease intravascular calcium and decrease SVR
how CCB’s (non dihydropiridines including verapamil and diltiazem) decrease BP
targets myocardium more than vessels
deceased inotropy, chronotropy, dromotropy, svr
what hydralazine dilates primarily and how it decreases BP
arteriodilator that increases NO and decreases SVR (after load)
what SNP dilates primarily and how it decreases BP
equal arterial and venodilator and increases NO, decreases SVR (after load) and decreases venous return (preload)
what NTG primarily dilates and how it decreases BP
primarily venules, increases NO, decreases venous return (pre load)
MOA of ACEI’s
inhibits ATII mediated vasoconstriction and inhibits aldosterone release